Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Database
Publication year range
1.
Dokl Biochem Biophys ; 478(1): 21-24, 2018 Jan.
Article in English | MEDLINE | ID: mdl-29536303

ABSTRACT

This article is devoted to presenting the hypothesis explaining the fact of a considerable prevalence of phenotypic males among the triploid pink salmon as well as the regular occurrence of intersexes, which were revealed by us. This hypothesis also explains the large proportion (in some cases) in pink salmon populations of the individuals whose genetic sex does not match the phenotypic sex. We assume that the genes encoding the factors that contribute to the transformation of individuals into males (but not the marker sequences of the Y chromosome) are present not only in the Y chromosome of pink salmon but also in the X chromosome, although in smaller quantities.


Subject(s)
Salmon/genetics , Sex Chromosomes/genetics , Sex Determination Processes/genetics , Animals , Diploidy , Female , Genotype , Male , Phenotype
2.
Ontogenez ; 44(6): 423-33, 2013.
Article in Russian | MEDLINE | ID: mdl-25438593

ABSTRACT

Fecundity and mass of eggs, as well as survival of offspring, of hatchery-reared small (less than 406 g) females of Atlantic salmon are determined. The absolute fecundity and mass of egg of artificially reared fish are sufficiently less than that of anadromous spawners. Small females are characterized by delayed spawning; histological analysis has demonstrated significant asynchrony in oocyte development of some specimens. Survival of offspring of dwarf females at the early stages of development is lower than of anadromous females. Our results agree completely with the published data. It is suggested that dwarf females are not able to withstand intraspecific and interspecific competition because of low reproductive ability. This explains rarity of natural populations of dwarf (landlocked) forms of Atlantic salmon.


Subject(s)
Oocytes/pathology , Ovary/abnormalities , Salmo salar/abnormalities , Animals , Female , Fertility , Oocytes/metabolism , Ovary/metabolism , Ovary/physiopathology
3.
Arkh Patol ; 73(5): 43-7, 2011.
Article in Russian | MEDLINE | ID: mdl-22288173

ABSTRACT

The aim of research has been the estimation of a proliferative potential as simultaneous detection of a proliferative cells number (Ki-67 index) and duration of mitosis (nucleolar argyrophilic protein expression--B23/nucleophosmin and C23/nucleolin) at patients with adrenocortical cancer. In according to lifetime of patients after operation 2 groups had been sorted out. The first one included patients surviving 56.12 months, the second one--9.25 months. We've found out that different aspects of tumor diagnosis as well distinction of benignant or malignant tumor growth, a malignant degree of tumors, a prognostic criteria of illness, survival of patients etc. must be characterized by total research both a proliferative cells fraction (Ki-67 index) and a rate of mitosis (expressions of B23/nucleophosmin and C23/nucleolin).


Subject(s)
Adrenal Cortex Neoplasms , Antigens, Neoplasm/biosynthesis , Gene Expression Regulation, Neoplastic , Neoplasm Proteins/biosynthesis , Adrenal Cortex Neoplasms/metabolism , Adrenal Cortex Neoplasms/mortality , Adrenal Cortex Neoplasms/surgery , Adrenal Cortex Neoplasms/ultrastructure , Disease-Free Survival , Female , Humans , Male , Mitosis , Survival Rate
4.
Arkh Patol ; 72(4): 3-6, 2010.
Article in Russian | MEDLINE | ID: mdl-21086628

ABSTRACT

Papillary thyroid cancer (PTC) was ascertained to be characterized by a significant expression of matrix metalloproteinases (MMP-2 and 9) and a TIMP-2 inhibitor and decreased TIMP-1 accumulation in the cytoplasm of tumor cells; at the same time a combination of high cytoplasmic MMP-9 expression with no TIMP-1, as well as triple positive co-expression of MMP-2, MMP-9, and TIMP-2 are poor immunohistochemical indicators. The results of the performed study suggest that the detection of the types of expression of MMP-9+/TIMP-1 and MMP-2+/MMP-9+/TIMP-2+ is associated with the possible progression of a tumor process and concurrent with poor clinical and morphological signs, such as the large size of the tumor, the presence of intravascular invasion and regional metastases, organ capsular invasion, and low ultrastructural tumor cell differentiation. Thus, changes in the tumor expression of the extracellular matrix enzymes MMR-2 and MMP-9 and their inhibitors TIMP-1 and TIMP-2 along with the major clinical, morphological, and ultrastructural signs of the disease are important additional indicators for analyzing the malignant potential of PTC.


Subject(s)
Biomarkers, Tumor/biosynthesis , Gene Expression Regulation, Neoplastic , Matrix Metalloproteinase 2/biosynthesis , Matrix Metalloproteinase 9/biosynthesis , Tissue Inhibitor of Metalloproteinase-1/biosynthesis , Tissue Inhibitor of Metalloproteinase-2/biosynthesis , Adult , Carcinoma , Carcinoma, Papillary , Female , Humans , Male , Middle Aged , Neoplasm Invasiveness , Neoplasm Metastasis , Thyroid Cancer, Papillary , Thyroid Neoplasms/metabolism , Thyroid Neoplasms/ultrastructure
5.
Arkh Patol ; 72(4): 49-52, 2010.
Article in Russian | MEDLINE | ID: mdl-21086640

ABSTRACT

The prognosis in papillary thyroid cancer (PTC) is usually good. Ten-year survival can be seen in 90-98% of patients. Immunohistochemical study (antigen K-67) ascertained that a female patient with PTC had a low number of proliferating cells, which is usually seen in the favorable course of the disease. However, in the presented case, PTC was highly aggressive and showed a significant invasive growth, provided regional and distant metastases, rapidly progressed and, despite the performed surgical treatment, the patient died due to disease progression 3 months after surgery. This discrepancy between the number of proliferating cells and the aggressive course of PTC should be explained by the high expression of argyrophilic nucleolar organizer region associated proteins nucleofozmin and nucleolin, detected by immunohistochemical study, which is known to cause an increase in the rate of a mitotic cycle rate and to promote intercellular adhesion and enhancement of invasive growth and metastatic spread. Various factors involved in the regulation of proliferation of cells and their capacity for invasion and metastasis should be studied to make the most objective estimation of the degree of malignancy of a tumor and its prognosis.


Subject(s)
Antigens, Nuclear/biosynthesis , Gene Expression Regulation, Neoplastic , Mitosis , Carcinoma , Carcinoma, Papillary , Female , Humans , Ki-67 Antigen/biosynthesis , Middle Aged , Neoplasm Invasiveness , Neoplasm Metastasis , Prognosis , Thyroid Cancer, Papillary , Thyroid Neoplasms/metabolism , Thyroid Neoplasms/pathology
6.
Vopr Onkol ; 56(4): 435-42, 2010.
Article in Russian | MEDLINE | ID: mdl-20968023

ABSTRACT

Infantile myofibroma (myofibromatosis) (IM) is a mesenchymal tumor of soft tissues of the head, extremities and trunk. It is characterized by relapse-free infiltrative growth. It consists of neoplastic myofibroblasts at varying stage of cell differentiation which form multi-structured tumor zones. IM's morphological differentiated diagnosis is established vis-a-vis other varieties of tumor and reactive nodular structures of fibroblasts, primarily, infantile hemangiopericytomas and desmoid fibromatosis. Immunohistological and ultrastructural examination of tumor is required for making correct diagnosis of IM.


Subject(s)
Biomarkers, Tumor/analysis , Myofibroma/diagnosis , Myofibromatosis/diagnosis , Child , Child, Preschool , Diagnosis, Differential , Female , Fibromatosis, Aggressive/diagnosis , Humans , Immunohistochemistry , Infant , Male , Myofibroma/metabolism , Myofibroma/pathology , Myofibromatosis/metabolism , Myofibromatosis/pathology
SELECTION OF CITATIONS
SEARCH DETAIL
...